BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11075835)

  • 1. Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy.
    Leniger T; Wiemann M; Bingmann D; Hufnagel A; Bonnet U
    Cephalalgia; 2000 Jul; 20(6):533-7. PubMed ID: 11075835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels.
    Bertrand S; Ng GY; Purisai MG; Wolfe SE; Severidt MW; Nouel D; Robitaille R; Low MJ; O'Neill GP; Metters K; Lacaille JC; Chronwall BM; Morris SJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):15-24. PubMed ID: 11408520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
    Eckstein-Ludwig U; Fei J; Schwarz W
    Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
    Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
    Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro.
    Honmou O; Kocsis JD; Richerson GB
    Epilepsy Res; 1995 Mar; 20(3):193-202. PubMed ID: 7796791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin.
    Dalby NO; Nielsen EB
    Epilepsy Res; 1997 Jul; 28(1):63-72. PubMed ID: 9255600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drugs in migraine prophylaxis: state of the art.
    Capuano A; Vollono C; Mei D; Pierguidi L; Ferraro D; Di Trapani G
    Clin Ter; 2004; 155(2-3):79-87. PubMed ID: 15244112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception.
    Laughlin TM; Tram KV; Wilcox GL; Birnbaum AK
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1168-75. PubMed ID: 12183677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA.
    Stahl SM
    J Clin Psychiatry; 2004 Mar; 65(3):291-2. PubMed ID: 15096065
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and neurochemical aspects of diaphragmatic myoclonus].
    Gazulla Abío J; Feijóo de Freixo M; Val Adán P; Benavente Aguilar I
    Neurologia; 2003 Oct; 18(8):473-7. PubMed ID: 14615952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices.
    Köhling R; König K; Lücke A; Mayer T; Wolf P; Speckmann EJ
    Epilepsia; 2002 Dec; 43(12):1455-61. PubMed ID: 12460245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis.
    Honmou O; Oyelese AA; Kocsis JD
    Brain Res; 1995 Sep; 692(1-2):273-7. PubMed ID: 8548315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
    Rekling JC
    Neurosci Lett; 2003 Jan; 335(3):167-70. PubMed ID: 12531459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different actions of gabapentin and baclofen in hippocampus from weaver mice.
    Bertrand S; Morin F; Lacaille JC
    Hippocampus; 2003; 13(4):525-8. PubMed ID: 12836919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
    McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
    Psychopharmacology (Berl); 2008 May; 197(4):591-600. PubMed ID: 18264695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticonvulsants in preventive therapy of migraine].
    Filatova EG; Klimov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(10):65-8. PubMed ID: 14628591
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
    Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
    Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release.
    Wu Y; Wang W; Richerson GB
    J Neurophysiol; 2003 Apr; 89(4):2021-34. PubMed ID: 12612025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.
    Costa C; Leone G; Saulle E; Pisani F; Bernardi G; Calabresi P
    Stroke; 2004 Feb; 35(2):596-600. PubMed ID: 14726544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
    Sills GJ
    Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.